-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IscJuVScysUt90UwcWJJsFHTyxD9tV2eKmk/OVI29DnZs5w7k+Yj7op9jiuNt4Hq 3V4NEY48KfusfR9/Nm/nuw== 0001144204-08-019703.txt : 20080401 0001144204-08-019703.hdr.sgml : 20080401 20080401115200 ACCESSION NUMBER: 0001144204-08-019703 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071231 FILED AS OF DATE: 20080401 DATE AS OF CHANGE: 20080401 EFFECTIVENESS DATE: 20080401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPTIGENEX INC. CENTRAL INDEX KEY: 0001168776 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 201678933 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51248 FILM NUMBER: 08728052 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-905-0189 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: VIBRANT HEALTH INTERNATIONAL DATE OF NAME CHANGE: 20020308 NT 10-K 1 v109301_nt10k.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SEC File Number: 000-51248
 
CUSIP Number: 683886 10 5
FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ]
[ ] Form N-CSR
 
For Fiscal Year Ended: December 31, 2007
 
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: _____________________
 
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
 
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 

 
PART I - REGISTRANT INFORMATION

Optigenex Inc.

Full Name of Registrant


Former Name if Applicable

1170 Valley Brook Avenue, 2nd Floor, Suite B

Address of Principal Executive Office (Street and Number)

Lyndhurst, NJ 07071

City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 
(a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort orexpense.
   
[X]
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR orForm N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; orthe subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof,will be filed on or before the fifth calendar day following the prescribed due date; and
   
 
(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
 
 

 
 
PART III - NARRATIVE
 
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
 
The Company's Annual Report on Form 10-K for the year ended December 31, 2007 cannot be filed within the prescribed time period because the Company requires additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Form 10-K. The Company's Annual Report on Form 10-K will be filed on or before the 15th calendar day following the prescribed due date.
 
PART IV - OTHER INFORMATION
 
(1) Name and telephone number of person to contact in regard to this notification
Daniel Zwiren
(201)
355-2098
(Name)
(Area Code)
(Telephone Number)
 
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
[X] Yes [ ] No
 
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
 
 

 
Optigenex Inc.  
(Name of Registrant as specified in Charter)
 
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
 

Date: April 1, 2008
By: /s/ Daniel Zwiren
 
Its: Chief Executive Officer
 
 
2

 
-----END PRIVACY-ENHANCED MESSAGE-----